Nifty

:

17196.70

Sensex

:

57696.46

-204.95 (-1.18%)
-764.83 (-1.31%)

Login

Nifty
Sensex

:
:

17196.70
57696.46

-204.95 (-1.18%)
-764.83 (-1.31%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

66/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

188.90

03-Dec-2021

Open
High
Low
Previous Close

191.75
192.85
186.20
191.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

160052
302.38
232.00
99.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,830.80
22.72
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,872.97
0.05%
8.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

19.29
14.71
11.61

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.59
29.60
12.78

PAT CAGR (%)

10 Years
5 Years
3 Years

39.99
37.44
26.33

P:E (Median)

8 Years
5 Years
3 Years

35.75
38.60
28.20

P:BV (Average)

8 Years
5 Years
3 Years

8.00
8.00
8.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.58
18.37
15.50

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var%
Net Sales 194.14 128.42 51.18% 250.76 60.80 312.43% 131.93 87.07 51.52% 144.41 97.74 47.75%
Expenses 158.31 99.01 59.89% 205.11 57.45 257.02% 108.18 74.68 44.86% 119.94 85.81 39.77%
EBITDA 35.83 29.40 21.87% 45.65 3.35 1,262.69% 23.75 12.39 91.69% 24.47 11.93 105.11%
EBIDTM 18.46% 22.90% 18.20% 5.51% 18.00% 14.23% 16.94% 12.20%
Other Income 0.31 2.26 -86.28% 1.23 0.78 57.69% 0.66 1.27 -48.03% 0.60 3.06 -80.39%
Interest 1.55 3.60 -56.94% 1.21 3.38 -64.20% 2.87 3.62 -20.72% 3.68 3.45 6.67%
Depreciation 4.20 5.05 -16.83% 4.13 3.55 16.34% 4.48 3.75 19.47% 3.22 2.11 52.61%
PBT 30.39 23.01 32.07% 41.54 -2.80 - 17.05 6.29 171.07% 18.17 9.42 92.89%
Tax 7.05 5.68 24.12% 10.33 -1.36 - 4.18 1.31 219.08% 4.99 2.40 107.92%
PAT 23.34 17.33 34.68% 31.21 -1.43 - 12.87 4.97 158.95% 13.18 7.02 87.75%
PATM 12.02% 13.50% 12.45% -2.36% 9.76% 5.71% 9.13% 7.18%
EPS 2.41 1.79 34.64% 3.22 -0.15 - 1.33 0.51 160.78% 1.36 0.72 88.89%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 721.24 487.70 378.84 350.77 305.58 245.52 202.20 151.55 123.01 100.14 83.57 Net Sales Growth 92.83% 28.74% 8.00% 14.79% 24.46% 21.42% 33.42% 23.20% 22.84% 19.83% Cost Of Goods Sold 400.13 226.12 156.47 161.37 128.58 107.42 90.84 73.47 55.61 46.05 40.87 Gross Profit 321.11 261.58 222.37 189.40 177.01 138.10 111.35 78.08 67.40 54.09 42.70 GP Margin 44.52% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% 51.52% 54.79% 54.01% 51.09% Total Expenditure 591.54 403.78 326.72 304.78 266.80 222.57 182.51 137.28 110.98 89.40 76.23 Power & Fuel Cost - 9.94 8.23 3.43 3.58 3.51 3.57 3.16 2.95 3.21 2.50 % Of Sales - 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% 2.09% 2.40% 3.21% 2.99% Employee Cost - 66.22 58.59 46.85 44.62 41.03 31.95 19.23 12.25 5.45 4.37 % Of Sales - 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% 12.69% 9.96% 5.44% 5.23% Manufacturing Exp. - 46.74 43.26 43.16 37.69 28.94 23.54 15.48 17.33 9.14 7.49 % Of Sales - 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% 10.21% 14.09% 9.13% 8.96% General & Admin Exp. - 23.69 32.47 32.32 31.50 27.03 20.56 13.56 8.82 3.79 4.96 % Of Sales - 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% 8.95% 7.17% 3.78% 5.94% Selling & Distn. Exp. - 17.87 17.35 11.36 13.26 9.11 8.19 8.78 12.41 19.92 15.85 % Of Sales - 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% 5.79% 10.09% 19.89% 18.97% Miscellaneous Exp. - 13.20 10.36 6.29 7.57 5.53 3.85 3.61 1.61 1.84 15.85 % Of Sales - 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% 2.38% 1.31% 1.84% 0.22% EBITDA 129.70 83.92 52.12 45.99 38.78 22.95 19.69 14.27 12.03 10.74 7.34 EBITDA Margin 17.98% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% 9.42% 9.78% 10.72% 8.78% Other Income 2.80 3.73 5.79 4.17 2.86 1.44 0.66 0.57 0.63 0.39 0.37 Interest 9.31 13.63 13.91 10.16 8.88 6.34 6.20 4.46 3.92 3.69 2.85 Depreciation 16.03 16.31 13.86 4.65 4.40 3.68 3.79 3.85 2.47 2.18 1.88 PBT 107.15 57.71 30.13 35.35 28.37 14.37 10.36 6.53 6.27 5.26 2.97 Tax 26.55 13.48 7.44 13.41 13.48 5.35 3.03 2.37 2.01 1.93 1.44 Tax Rate 24.78% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% 36.29% 32.06% 36.69% 48.48% PAT 80.60 44.23 22.69 21.94 16.48 9.02 7.32 4.16 4.26 3.33 1.53 PAT before Minority Interest 80.60 44.23 22.69 21.94 16.48 9.02 7.32 4.16 4.26 3.33 1.53 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.18% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% 2.74% 3.46% 3.33% 1.83% PAT Growth 188.99% 94.93% 3.42% 33.13% 82.71% 23.22% 75.96% -2.35% 27.93% 117.65% EPS 8.32 4.56 2.34 2.26 1.70 0.93 0.76 0.43 0.44 0.34 0.16

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 173.44 129.32 75.35 54.14 37.33 33.96 27.10 26.21 22.39 19.51 Share Capital 9.69 9.69 7.78 7.78 7.74 7.74 7.74 7.74 7.74 7.74 Total Reserves 163.74 119.63 67.56 46.35 29.59 26.22 19.36 18.47 14.66 11.78 Non-Current Liabilities 54.96 37.79 17.16 12.54 9.16 14.56 16.58 24.63 23.53 8.75 Secured Loans 35.43 19.52 11.25 4.43 3.20 4.84 8.62 10.17 13.72 1.65 Unsecured Loans 0.00 0.03 0.06 3.89 3.42 2.82 2.88 4.71 4.72 2.67 Long Term Provisions 10.23 7.93 1.86 2.26 2.29 1.39 1.41 1.35 1.19 1.00 Current Liabilities 219.85 325.60 217.72 168.55 128.18 103.68 83.61 60.31 43.65 47.06 Trade Payables 113.03 117.07 77.81 75.98 43.74 52.62 49.53 31.80 20.14 22.22 Other Current Liabilities 28.16 22.99 16.28 17.24 20.75 14.10 13.01 11.28 7.74 6.42 Short Term Borrowings 16.32 93.10 84.69 69.17 46.97 32.28 17.90 14.77 13.74 15.32 Short Term Provisions 62.33 92.44 38.95 6.16 16.73 4.67 3.16 2.47 2.04 3.10 Total Liabilities 448.25 492.71 310.23 235.23 174.67 152.20 127.29 111.15 89.57 75.32 Net Block 99.97 82.58 24.45 22.85 21.96 22.15 25.11 30.23 26.83 17.71 Gross Block 148.64 114.98 37.19 31.00 25.65 51.31 50.81 48.46 42.59 31.60 Accumulated Depreciation 48.67 32.40 12.74 8.15 3.68 29.17 25.71 18.23 15.76 13.89 Non Current Assets 131.48 133.58 46.34 37.02 31.42 32.69 35.81 41.84 39.36 24.33 Capital Work in Progress 13.40 30.61 9.63 2.05 0.04 0.00 0.00 0.00 2.98 1.07 Non Current Investment 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 17.12 18.54 10.16 8.73 7.60 9.01 9.17 11.32 7.34 5.49 Other Non Current Assets 0.98 1.84 2.09 3.38 1.82 1.52 1.52 0.28 2.20 0.05 Current Assets 316.77 359.13 263.89 198.20 143.25 119.51 91.48 69.30 50.22 50.99 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 94.40 122.46 94.28 94.20 63.02 50.26 36.80 26.12 20.00 16.91 Sundry Debtors 124.50 106.97 103.18 80.80 52.12 56.23 33.38 28.21 20.01 22.57 Cash & Bank 13.18 16.37 7.59 7.50 5.64 6.16 6.21 2.54 1.28 0.96 Other Current Assets 84.69 0.84 1.10 0.38 22.47 6.86 15.08 12.44 8.93 10.55 Short Term Loans & Adv. 84.00 112.48 57.74 15.33 21.38 6.10 12.45 9.60 7.19 10.22 Net Current Assets 96.92 33.53 46.17 29.66 15.07 15.84 7.87 8.99 6.57 3.93 Total Assets 448.25 492.71 310.23 235.22 174.67 152.20 127.29 111.14 89.58 75.32

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 89.06 47.10 5.21 -4.82 -4.13 -4.32 11.15 10.87 5.26 5.16 PBT 57.71 30.13 35.35 29.95 14.37 11.19 6.53 6.27 5.26 2.97 Adjustment 30.79 24.63 13.35 12.07 9.75 8.84 8.19 6.27 5.95 4.86 Changes in Working Capital 9.97 2.48 -33.52 -30.40 -23.70 -21.31 -1.60 -0.19 -4.42 -1.87 Cash after chg. in Working capital 98.47 57.24 15.18 11.63 0.42 -1.28 13.12 12.36 6.79 5.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 -1.96 -1.49 -1.54 -0.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -0.38 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.51 -42.53 -12.99 -8.84 -4.69 -0.51 -2.39 -2.78 -13.26 -3.33 Net Fixed Assets -16.45 -98.77 -13.77 -7.36 25.62 -0.50 -2.35 -2.89 -12.90 -3.26 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 7.94 56.24 0.78 -1.48 -30.31 -0.01 -0.04 0.11 -0.36 -0.07 Cash from Financing Activity -78.62 -4.21 7.71 14.40 7.41 4.78 -5.09 -6.82 8.32 -1.82 Net Cash Inflow / Outflow 1.94 0.37 -0.08 0.75 -1.41 -0.05 3.67 1.26 0.32 0.02 Opening Cash & Equivalents 4.26 3.90 3.74 2.99 4.28 6.21 2.54 1.28 0.96 0.95 Closing Cash & Equivalent 6.20 4.26 3.66 3.74 2.87 6.16 6.21 2.54 1.28 0.96

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 17.89 13.34 9.68 6.96 4.83 4.39 3.50 3.39 2.90 2.52 ROA 9.40% 5.65% 8.04% 8.04% 5.52% 5.24% 3.49% 4.25% 4.04% 2.20% ROE 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% 15.60% 17.55% 15.89% 8.05% ROCE 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% 18.38% 17.45% 18.44% 15.02% Fixed Asset Turnover 3.71 5.14 10.57 11.21 6.77 4.19 3.22 2.86 2.85 2.83 Receivable days 86.30 97.98 93.16 76.39 75.93 76.38 70.29 67.55 73.52 84.97 Inventory Days 80.86 101.05 95.44 90.36 79.39 74.21 71.80 64.60 63.71 62.71 Payable days 111.92 115.05 115.32 80.93 87.99 110.87 119.47 95.34 87.64 91.90 Cash Conversion Cycle 55.24 83.98 73.27 85.82 67.32 39.73 22.62 36.81 49.59 55.78 Total Debt/Equity 0.32 0.90 1.30 1.47 1.52 1.26 1.21 1.27 1.55 1.05 Interest Cover 5.23 3.17 4.48 4.37 3.27 2.67 2.46 2.60 2.43 2.04

Top Investors:

sbi healthcare opportunities fund

jagdish n master

girish gulati huf

Annual Reports:

News Update:

Gufic Biosciences - Quarterly Results
3rd Nov 2021, 18:28 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback